Evidence map›Paper›PMID 32221310›Full record

ArticleNature communications2020

Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins.

Somnath Mukherjee, Satchal K Erramilli, Mark Ammirati, Frances J D Alvarez, Kimberly F Fennell, Michael D Purdy, Blazej M Skrobek, Katarzyna Radziwon, John Coukos, Yanyong Kang and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. The structure of the dopamine DScience advances · 2026
    Article
  4. Activation of the angiotensin II type I receptor by a nonpeptide agonist.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. A novel fusion tool to enable G protein-coupled receptor structure determination.Acta crystallographica. Section D, Structural biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Structural evolution of the MTCH family of mitochondrial insertases.bioRxiv : the preprint server for biology · 2026
    Article
  13. Optimized bacterial expression of a synthetic BRIL antibody.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  14. Review
  15. Article
  16. Miniprotein inhibitors of thebioRxiv : the preprint server for biology · 2026
    Article
  17. Hidden gems bring proteins into view.Nature chemical biology · 2026
    Article
  18. Article
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Somnath MukherjeeDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.
Satchal K ErramilliDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.
Mark AmmiratiMedicine Design, Worldwide Research and Development, Pfizer Inc., Eastern Point Road, Groton, CT, 06340, USA.
Frances J D AlvarezMedicine Design, Worldwide Research and Development, Pfizer Inc., Eastern Point Road, Groton, CT, 06340, USA.
Kimberly F FennellMedicine Design, Worldwide Research and Development, Pfizer Inc., Eastern Point Road, Groton, CT, 06340, USA.
Michael D PurdyDepartment of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, USA.
Blazej M SkrobekDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-8487-6293
Katarzyna RadziwonDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.
John CoukosDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-7860-7847
Yanyong KangCenter for Cancer and Cell Biology, Structural Biology Program, Van Andel Research Institute, Grand Rapids, MI, USA.
Przemysław DutkaDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-3819-1618
Xiang GaoCenter for Cancer and Cell Biology, Structural Biology Program, Van Andel Research Institute, Grand Rapids, MI, USA.
Xiayang QiuMedicine Design, Worldwide Research and Development, Pfizer Inc., Eastern Point Road, Groton, CT, 06340, USA.
Mark YeagerDepartment of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, USA.
H Eric XuCenter for Cancer and Cell Biology, Structural Biology Program, Van Andel Research Institute, Grand Rapids, MI, USA.
Seungil HanMedicine Design, Worldwide Research and Development, Pfizer Inc., Eastern Point Road, Groton, CT, 06340, USA.ORCID http://orcid.org/0000-0002-1070-3880
Anthony A KossiakoffDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA. koss@bsd.uchicago.edu.
Pfizer (United States) · USUniversity of Chicago · USVan Andel Institute · USUniversity of Virginia · USCalifornia Institute of Technology · USUniversity of Illinois Chicago · USUniversity of Wisconsin–Madison · US

Funding

X-ray Cryst. CoreP50GM082545 · NIGMS · UNIVERSITY OF UTAH · PI SUNDQUIST, WESLEY I. · 2007 to 2018
$51.1M
Virus TransmissionP50AI150464 · NIAID · UNIVERSITY OF UTAH · PI HOPE, THOMAS · 2019 to 2021
$14.9M
Chaperone-Assisted Structure Determination of Membrane ProteinsR01GM117372 · NIGMS · UNIVERSITY OF CHICAGO · PI ANTHONY A KOSSIAKOFF · 2016 to 2026
$4.0M
Structural Biology of Connexin Membrane ChannelsR01GM138532 · NIGMS · UNIVERSITY OF VIRGINIA · PI YEAGER, MARK JAY · 2020 to 2023
$1.9M
Structure Analysis of Viral Assembly MechanismsR01GM128507 · NIGMS · UNIVERSITY OF VIRGINIA · PI YEAGER, MARK JAY · 2018 to 2019
$1.5M
NIAID NIH HHS P50 AI150464NIGMS NIH HHS P50 GM082545NIGMS NIH HHS R01 GM117372NIGMS NIH HHS R01 GM128507NIGMS NIH HHS R01 GM138532
6 · The paper itself

Abstract

We propose the concept of universal fiducials based on a set of pre-made semi-synthetic antibodies (sABs) generated by customized phage display selections against the fusion protein BRIL, an engineered variant of apocytochrome b562a. These sABs can bind to BRIL fused either into the loops or termini of different GPCRs, ion channels, receptors and transporters without disrupting their structure. A crystal structure of BRIL in complex with an affinity-matured sAB (BAG2) that bound to all systems tested delineates the footprint of interaction. Negative stain and cryoEM data of several examples of BRIL-membrane protein chimera highlight the effectiveness of the sABs as universal fiducial marks. Taken together with a cryoEM structure of sAB bound human nicotinic acetylcholine receptor, this work demonstrates that these anti-BRIL sABs can greatly enhance the particle properties leading to improved cryoEM outcomes, especially for challenging membrane proteins.

Indexed as

AntibodiesCell MembraneCell Surface Display TechniquesCryoelectron MicroscopyCrystallography, X-RayHumansMembrane ProteinsModels, MolecularPolymersPropylaminesProtein BindingProtein ConformationAntibodiesIFITM5 protein, humanMembrane ProteinsPolymersPropylamines

Identifiers

PMID32221310
PMCPMC7101349
OpenAlexW3013945060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.